maccura(SZ:300463) Sou Hu Cai Jing·2025-07-03 09:18Group 1 - The core viewpoint of the news highlights that Maike Biological's stock price closed at 12.03 yuan, with a PE ratio of 242.83, marking a new low in 19 days, and a total market capitalization of 7.368 billion yuan [1] - The average PE ratio for the medical device industry is 51.48, with a median of 36.88, positioning Maike Biological at the 118th rank within the industry [1] - As of March 31, 2025, the number of shareholders for Maike Biological is 35,022, a decrease of 1,242 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Group 2 - Maike Biological specializes in the research, production, sales, and related services of in vitro diagnostic products, with a wide range of testing reagents for various health conditions [2] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 510 million yuan, a year-on-year decrease of 17.22%, and a net profit of 23.98 million yuan, down 80.09% year-on-year, with a gross profit margin of 56.76% [2] - The PE ratio (TTM) for Maike Biological is 242.83, while the industry average is 51.48, indicating a significant disparity in valuation [3]